@article{JTD10342,
author = {Lauren K. Truby and Veli K. Topkara},
title = {Angiopoietin-2: marker or mediator of angiogenesis in continuous-flow left ventricular assist device patients?},
journal = {Journal of Thoracic Disease},
volume = {8},
number = {11},
year = {2016},
keywords = {},
abstract = {Recent advances in left ventricular assist device (LVAD) technology have revolutionized care of patients with end-stage heart failure (HF) both as bridge-to-transplantation and as destination therapy (1,2). Over the last decade, older generation pulsatile-flow LVADs (PF-LVADs) were replaced with new generation continuous-flow LVADs (CF-LVADs) due to their ease of implantation, improved durability, and vastly superior outcomes demonstrated in clinical trials.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/10342}
}